Article
Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis.
Gastroenterology - 1 Nov 2011
Wirtz Stefan, Billmeier Ulrike, Mchedlidze Tamuna, Blumberg Richard S, Neurath Markus F
Abstract excerpt
BACKGROUND & AIMS: The soluble hematopoietin receptor Epstein-Barr virus-induced protein (EBI)-3 is an immune regulator that has been associated with the pathogenesis of inflammatory bowel disease. However, the concept that EBI3 is part of an interleukin (IL)-27 heterodimer that mediates chronic inflammatory and autoimmune diseases has been challenged by the description of IL-35, a bioactive cytokine comprising...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
